Teva Pharmaceutical Industries Limited (TEVA)

NYQ – Real Time Price. Currency in USD

35.81

-0.03 (-0.08%)

At close: May 12, 2026, 4:00 PM EDT

35.93

+0.10 (0.28%)

Pre-market: May 13, 2026, 9:17 AM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

17.46B

16.59B

15.81B

14.86B

Cost of goods sold

-8.39B

-8.52B

-8.18B

-7.92B

Gross Profit

9.07B

8.07B

7.63B

6.93B

Operating expenses (excl. COGS)

-5.03B

-4.72B

-4.44B

-4.27B

Operating Income

4.05B

3.34B

3.19B

2.67B

Non-operating income, total

-2.82B

-4.63B

-3.81B

-5.82B

Pretax income

1.23B

-1.29B

-622M

-3.15B

Equity in earnings

15M

21M

Taxes

181M

-679M

640M

Non-controlling/minority interest

-8M

322M

56M

53M

After tax other income/expense

Net income before discontinued operations

1.42B

-1.65B

-558M

-2.44B

Teva Pharmaceutical Industries Limited (TEVA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Teva Pharmaceutical Industries Limited (TEVA)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Teva Pharmaceutical Industries Limited (TEVA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Teva Pharmaceutical Industries Limited (TEVA)

Income Statement (Annual)

Income Statement (Annual)